A detailed history of Pinnacle Associates LTD transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Pinnacle Associates LTD holds 458,979 shares of IONS stock, worth $15.6 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
458,979
Previous 453,379 1.24%
Holding current value
$15.6 Million
Previous $21.6 Million 14.91%
% of portfolio
0.29%
Previous 0.35%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$40.06 - $51.86 $224,336 - $290,416
5,600 Added 1.24%
458,979 $18.4 Million
Q2 2024

Jul 30, 2024

SELL
$36.45 - $47.7 $232,514 - $304,278
-6,379 Reduced 1.39%
453,379 $21.6 Million
Q1 2024

Apr 26, 2024

BUY
$42.03 - $53.55 $32,741 - $41,715
779 Added 0.17%
459,758 $19.9 Million
Q4 2023

Jan 19, 2024

SELL
$43.39 - $51.63 $175,989 - $209,411
-4,056 Reduced 0.88%
458,979 $23.2 Million
Q3 2023

Oct 23, 2023

SELL
$38.5 - $47.13 $584,006 - $714,914
-15,169 Reduced 3.17%
463,035 $21 Million
Q2 2023

Jul 26, 2023

SELL
$34.73 - $43.33 $432,423 - $539,501
-12,451 Reduced 2.54%
478,204 $19.6 Million
Q1 2023

May 04, 2023

SELL
$33.58 - $41.2 $137,510 - $168,714
-4,095 Reduced 0.83%
490,655 $17.5 Million
Q4 2022

Jan 31, 2023

BUY
$37.12 - $46.52 $61,433 - $76,990
1,655 Added 0.34%
494,750 $18.7 Million
Q4 2022

Jan 25, 2023

SELL
$37.12 - $46.52 $289,350 - $362,623
-7,795 Reduced 1.56%
493,095 $0
Q3 2022

Oct 31, 2022

SELL
$36.54 - $48.66 $546,967 - $728,391
-14,969 Reduced 2.9%
500,890 $22.2 Million
Q2 2022

Aug 02, 2022

SELL
$31.71 - $43.0 $193,716 - $262,687
-6,109 Reduced 1.17%
515,859 $19.1 Million
Q1 2022

May 05, 2022

SELL
$29.88 - $37.04 $569,990 - $706,575
-19,076 Reduced 3.53%
521,968 $19.3 Million
Q4 2021

Feb 02, 2022

SELL
$25.61 - $35.1 $55,881 - $76,588
-2,182 Reduced 0.4%
541,044 $16.5 Million
Q3 2021

Oct 19, 2021

BUY
$33.54 - $40.55 $63,189 - $76,396
1,884 Added 0.35%
543,226 $18.2 Million
Q2 2021

Aug 02, 2021

BUY
$34.54 - $47.25 $974,649 - $1.33 Million
28,218 Added 5.5%
541,342 $21.6 Million
Q1 2021

May 12, 2021

SELL
$42.51 - $63.78 $1.73 Million - $2.6 Million
-40,790 Reduced 7.36%
513,124 $23.1 Million
Q4 2020

Jan 26, 2021

SELL
$45.3 - $60.27 $1.31 Million - $1.75 Million
-28,955 Reduced 4.97%
553,914 $31.3 Million
Q3 2020

Oct 23, 2020

SELL
$47.45 - $62.95 $893,388 - $1.19 Million
-18,828 Reduced 3.13%
582,869 $27.7 Million
Q2 2020

Aug 14, 2020

SELL
$46.85 - $61.05 $946,932 - $1.23 Million
-20,212 Reduced 3.25%
601,697 $35.5 Million
Q1 2020

May 13, 2020

SELL
$41.6 - $63.4 $3.36 Million - $5.11 Million
-80,650 Reduced 11.48%
621,909 $29.4 Million
Q4 2019

Feb 03, 2020

SELL
$53.85 - $65.27 $3.52 Million - $4.27 Million
-65,401 Reduced 8.52%
702,559 $42.4 Million
Q3 2019

Nov 08, 2019

SELL
$59.06 - $72.15 $1.91 Million - $2.33 Million
-32,308 Reduced 4.04%
767,960 $46 Million
Q2 2019

Aug 05, 2019

SELL
$62.09 - $86.14 $4.83 Million - $6.7 Million
-77,763 Reduced 8.86%
800,268 $51.4 Million
Q1 2019

May 10, 2019

SELL
$52.92 - $81.17 $1.64 Million - $2.51 Million
-30,915 Reduced 3.4%
878,031 $71.3 Million
Q4 2018

Feb 05, 2019

SELL
$43.37 - $59.54 $2.65 Million - $3.64 Million
-61,119 Reduced 6.3%
908,946 $49.1 Million
Q3 2018

Nov 13, 2018

SELL
$42.88 - $53.7 $5.28 Million - $6.61 Million
-123,033 Reduced 11.26%
970,065 $50 Million
Q2 2018

Aug 08, 2018

SELL
$40.53 - $50.7 $6.12 Million - $7.65 Million
-150,877 Reduced 12.13%
1,093,098 $45.5 Million
Q1 2018

May 11, 2018

SELL
$44.08 - $55.05 $1.99 Million - $2.49 Million
-45,246 Reduced 3.51%
1,243,975 $54.8 Million
Q4 2017

Feb 12, 2018

SELL
$50.3 - $64.39 $5.49 Million - $7.03 Million
-109,244 Reduced 7.81%
1,289,221 $64.8 Million
Q3 2017

Nov 13, 2017

SELL
$45.56 - $59.57 $2.19 Million - $2.87 Million
-48,099 Reduced 3.33%
1,398,465 $70.9 Million
Q2 2017

Aug 09, 2017

BUY
N/A
1,446,564
1,446,564 $73.6 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.83B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Pinnacle Associates LTD Portfolio

Follow Pinnacle Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.